Emergopharmsp. z o.o. + limited partnership
KRS: NIP: REGON:
Overview
Status
Deleted
Activity period
2014-02-05 – 2026-09-10
Limited partner contribution
340,000.00 PLN
Registered address
ul. Jana Ciszewskiego 15, 02-777 Warszawa, Poland
Electronic delivery address
AE:PL-66053-26818-ABIDV-20
Financials
Revenue history (in m)
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Voivodeship · Mazowieckie5,588 / 142,058
Top 3.9%
Country · Poland18,489 / 495,976
Top 3.7%
Results vs voivodeship
Revenue
This companyUSD 14.32mMedianUSD 156.09kAverageUSD 5.80m
Net profit
This companyUSD 3.13mMedianUSD 2.43kAverageUSD 312.36k
Operating costs
This companyUSD 10.24mMedianUSD 131.09kAverageUSD 4.96m
Assets
This companyUSD 8.04mMedianUSD 162.70kAverageUSD 11.37m
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-04-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $150,328.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-05-01 | Participation of EMERGOPHARM in the BIOTECHNOLOGY AND PHARMACEUTICALS promotion programme to expand into new foreign markets | $78,505$78,505 | Operational Programme Smart Growth | |
| 2018-03-01 | Obtaining industrial property protection for an invention in the form of a pharmaceutical composition containing totarol as an active ingredient to counteract disturbances in the composition of the vaginal microbiota | $65,963$65,963 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-10 | Struck off the register | |
| 2023-09-08 | Address change (Ul. Józefa Piłsudskiego 11, 05-510, Konstancin-Jeziorna → Ul. Jana Ciszewskiego 15, 02-777, Warszawa) | |
| 2017-03-14 | Address change (Fredry 9, 05-532, Tomice → Ul. Józefa Piłsudskiego 11, 05-510, Konstancin-Jeziorna) | |
| 2017-03-14 | PKD change (Removed: 21 codes) | |
| 2014-02-05 | Entered in the register |
FAQ
Last updated: 2026-10-02